Fisher Asset Management, LLC

Position in CGON — CG Oncology, Inc.

CIK 850529 PLANO, TX

Position in CGON

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$31,473,433

New position

Shares Held

465,033

first reported quarter

Ownership

0.527%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 36.56708233609228.ToString("F0")% Shared 0.ToString("F0")% None 63.432917663907716.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fisher Asset Management, LLC holds $672,291,921 across 48 Biotechnology names. CGON ranks #7 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	1,113,568	$69,820,713
2	CYTK	Cytokinetics Inc	768,264	$50,636,280
3	RCUS	Arcus Biosciences, Inc.	2,190,404	$47,312,726
4	DNLI	Denali Therapeutics Inc.	2,436,895	$46,788,384
5	VRDN	Viridian Therapeutics, Inc.DE	1,768,295	$34,587,850
6	CLDX	Celldex Therapeutics, Inc.	1,013,648	$32,152,914
7	CGON	CG Oncology, Inc. This page	465,033	$31,473,433
8	IDYA	IDEAYA Biosciences, Inc.	882,699	$29,411,530

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$31,473,433	465,033	—	Shares	Defined	2026-05-05
No filing history on record for this holder in this stock.